NA
SNTI icon

NewEdge Advisors’s Senti Biosciences Holdings SNTI Stock Holding History

NewEdge Advisors’s Portfolio SNTI Stock Details SNTI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$9.74K Buy
+12,000
New +$11.6K ﹤0.01% 3409

Other funds holding SNTI

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
MVM
Menlo Ventures Management Menlo Park, California $327M AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

NewEdge Advisors's SNTI Position: Q1 2026 in Review

NewEdge Advisors opened a new position in Senti Biosciences Holdings (SNTI) in Q1 2026: 12,000 shares worth $9.74K. The stake represents ﹤0.01% of the portfolio and ranks #3409 among its holdings.

16 funds tracked by Wall St. Rank hold SNTI as of Q1 2026.

  • NewEdge Advisors held 12,000 shares of Senti Biosciences Holdings worth $9.74K as of Q1 2026.
  • Senti Biosciences Holdings was a new NewEdge Advisors position in Q1 2026.
  • Senti Biosciences Holdings made up ﹤0.01% of NewEdge Advisors's portfolio in Q1 2026, its #3409 holding.
  • 16 funds tracked by Wall St. Rank held Senti Biosciences Holdings as of Q1 2026.

Based on NewEdge Advisors's 13F filing for Q1 2026, filed 18 May 2026.